Back to Search
MEREDITH BARAD, MD
MD
Pain Medicine (Psychiatry & Neurology) Physician
NPI: 1568656353IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology Physician
Psychiatry & Neurology — Neurology
Code: 2084N0400X
A88123(CA)
Pain Medicine (Psychiatry & Neurology) PhysicianPrimary
Psychiatry & Neurology — Pain Medicine
Code: 2084P2900X
A88123(CA)
Education
STANFORD UNIVERSITY SCHOOL OF MEDICINE
Class of 2003
Clinical Trials (1)
1
Linked Trials
1
Recruiting
0
With Results
Research & Publications (18)
Botulinum Toxin as an Effective Treatment for Trigeminal Neuralgia in Surgical Practices.
PMID 35944492·Stereotact Funct Neurosurg·2022
8-other
The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta-analysis of randomized controlled trials.
PMID 31541518·Brain Behav·2019
1-meta
Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials.
PMID 27377706·J Headache Pain·2016
1-meta
Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial.
PMID 25263254·J Headache Pain·2014
2-rct
Therapeutic effect of Botulinum toxin-A in 88 patients with trigeminal neuralgia with 14-month follow-up.
PMID 24952600·J Headache Pain·2014
8-other
Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?
PMID 24251833·J Headache Pain·2013
2-rct
Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review.
PMID 23964790·J Headache Pain·2013
1-meta
The role of the amygdala in the extinction of conditioned fear.
PMID 16919522·Biol Psychiatry·2006
6-review
Fear extinction in rodents: basic insight to clinical promise.
PMID 16260129·Curr Opin Neurobiol·2005
6-review
Social modulation of associative fear learning by pheromone communication.
PMID 19117912·Learn Mem·2009
7-preclinical
The histone deacetylase inhibitor valproic acid enhances acquisition, extinction, and reconsolidation of conditioned fear.
PMID 18174372·Learn Mem·2008
7-preclinical
Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear.
PMID 17522015·Learn Mem·2007
7-preclinical
Combining pharmacotherapy with cognitive behavioral therapy: traditional and new approaches.
PMID 17075906·J Trauma Stress·2006
6-review
Temporally massed CS presentations generate more fear extinction than spaced presentations.
PMID 14570519·J Exp Psychol Anim Behav Process·2003
7-preclinical
An unbiased cDNA library prepared from isolated Aplysia sensory neuron processes is enriched for cytoskeletal and translational mRNAs.
PMID 14561869·J Neurosci·2003
7-preclinical
L-type voltage-gated calcium channels are required for extinction, but not for acquisition or expression, of conditional fear in mice.
PMID 12388619·J Neurosci·2002
7-preclinical
Local protein synthesis and its role in synapse-specific plasticity.
PMID 11084321·Curr Opin Neurobiol·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- Stanford University Medical Center, Pain Management Clinic, 300 Pasteur Dr., Rm A408
Stanford, CA 94305 - Phone
- (650) 723-6238
Quick Facts
- NPI
- 1568656353
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 23
- Clinical Trials
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile